| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/27/2011 | CA2453486C The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 09/27/2011 | CA2440630C Metalloproteinase inhibitors |
| 09/27/2011 | CA2370206C Pharmaceutical compositions for inhibition of cytokine production and secretion |
| 09/22/2011 | WO2011116155A1 Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions |
| 09/22/2011 | WO2011115225A1 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
| 09/22/2011 | WO2011115183A1 Novel monocyclic pyrimidine derivative |
| 09/22/2011 | WO2011115173A1 Monomaleate of benzothiazine compound |
| 09/22/2011 | WO2011114225A1 Beta-propiolactone for inactivation of viruses in pharmaceutical pancreatic enzyme preparations |
| 09/22/2011 | WO2011114224A1 Gastro-resistant enzyme pharmaceutical compositions |
| 09/22/2011 | WO2011113802A2 Imidazopyridine compounds, compositions and methods of use |
| 09/22/2011 | WO2011113801A1 Use of clostridium perfringens strain 23 to protect against necrotic enteritis |
| 09/22/2011 | WO2011053003A3 Gastric-retentive sustained release formulation containing pregabalin, polyethyleneoxide and pva-peg graft copolymer |
| 09/22/2011 | US20110230549 Pharmaceutical compositions for the treatment of pain |
| 09/22/2011 | US20110230536 Phenylpyrazole inhibitors of store operated calcium release |
| 09/22/2011 | US20110230519 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 09/22/2011 | US20110230517 Calcium receptor modulating agents |
| 09/22/2011 | US20110230516 CCR1 Antagonists and Methods of Use Therefor |
| 09/22/2011 | US20110230512 Pharmaceutical Composition |
| 09/22/2011 | US20110230511 Carboxamide bioisosteres of opiates |
| 09/22/2011 | US20110230493 1-OXA-8-Azaspiro [4,5] Decabe-8-Carboxamide Compounds as FAAH Inhibitors |
| 09/22/2011 | US20110230490 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 09/22/2011 | US20110230487 Arylsulfonamide ccr3 antagonists |
| 09/22/2011 | US20110230485 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors |
| 09/22/2011 | US20110230484 Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators |
| 09/22/2011 | US20110230477 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders |
| 09/22/2011 | US20110230468 Fused heterocyclic compounds and uses thereof |
| 09/22/2011 | US20110230448 Treatment and/or Prevention of Non-Viral Epithelial Damage |
| 09/22/2011 | US20110230446 Cathepsin cysteine protease inhibitors |
| 09/22/2011 | US20110230434 Use of s-adenosylmethionine, vitamin e, and vitamin c for the treatment of oxidative liver injury or insulin resistance |
| 09/22/2011 | US20110230415 Pharmaceutical Composition Containing GHRP-6 To Prevent And Eliminate Fibrosis And Other Pathological Deposits In Tissues |
| 09/22/2011 | US20110230414 Pyrrolopyrazine Kinase Inhibitors |
| 09/22/2011 | US20110229944 FAD4, FAD5, FAD5-2, AND FAD6, Novel Fatty Acid Desaturase Family Members and Uses Thereof |
| 09/22/2011 | US20110229584 Compound for the control of herpes simplex virus using glycyrrhizic acid, lipoic acid, allantoin, and slippery elm |
| 09/22/2011 | US20110229573 Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form |
| 09/22/2011 | US20110229534 Non-Irritating Oral Care Formulations |
| 09/22/2011 | US20110229490 Lyophilized Formulations of Engineered Anti-IL-23p19 Antibodies |
| 09/22/2011 | US20110229488 Progastrin and liver pathologies |
| 09/22/2011 | US20110229476 Monospecific and multispecific antibodies and method of use |
| 09/22/2011 | US20110229466 Vascular endothelial growth factor 2 |
| 09/22/2011 | US20110229461 PD-1 Antibodies |
| 09/22/2011 | US20110229435 Expression and purification of hip/pap and uses therefor |
| 09/22/2011 | DE102010012232A1 New imidazole useful in pharmaceutical preparation e.g. for prevention or treatment of cancer diseases, pathological effects of alcohol misuse, viral hepatitis, steatohepatitis, acute and chronic pancreatitis, toxic renal diseases |
| 09/22/2011 | DE102010012223A1 Pharmaceutical preparation, useful for the treatment of autoimmune disease, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, Crohn's disease or ulcerative colitis, comprises 12-imidazolyl-1-dodecanol |
| 09/22/2011 | CA2793686A1 Pharmaceutical compositions comprising a pancreatic enzyme preparation with viral infectivity reduced below a significant level and methods of preparing and using the same |
| 09/22/2011 | CA2793685A1 Gastro-resistant enzyme pharmaceutical compositions |
| 09/22/2011 | CA2793024A1 Imidazopyridine compounds, compositions and methods of use |
| 09/21/2011 | EP2366774A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366773A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366772A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366771A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366389A1 Severe sepsis preventive therapeutic agent |
| 09/21/2011 | EP2365975A1 Imidazopyridine derivatives which inhibit the secretion of gastric acid |
| 09/21/2011 | EP2365955A1 Aryl di-substituted propenone compounds |
| 09/21/2011 | EP2365817A1 Treatment |
| 09/21/2011 | EP2365747A1 Methods for treating gastrointestinal diseases |
| 09/21/2011 | EP2219642B1 Silibinin component for the treatment of hepatitis |
| 09/21/2011 | EP2144604B1 Methods for the treatment of chronic viral hepatitis C using RO 113-0830 |
| 09/21/2011 | EP2024354B1 1- [ (4- [benzoyl (methyl) amino]-3- (phenyl) butyl]azetidine derivatives for the treatment of gastrointestinal disorders 1 |
| 09/21/2011 | EP1572240B1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 09/21/2011 | EP1519956B1 Epha2 monoclonal antibodies and methods of use thereof |
| 09/21/2011 | EP1505963B9 Hepatitis c virus inhibitors |
| 09/21/2011 | EP1296998B1 Hcv variants |
| 09/21/2011 | EP1003728B1 2-(3-(4-(2-t-Butyl-6-trifluoromethylpyrimidin-4-yl)piperazin-1-yl)propylmercapto)pyrimidin-4-ol-fumarate |
| 09/21/2011 | CN102196807A Water insoluble polymer: starch-based film coatings for colon targeting |
| 09/21/2011 | CN102196806A Water insoluble polymer: indigestible water-soluble polysaccharide film coatings for colon targeting |
| 09/21/2011 | CN102191211A Salmonellapullorum attenuated mutant strain deltaS6702(SpiA) and construction method thereof |
| 09/21/2011 | CN102191210A Salmonella pullorum attenuated mutant strain delta S6702 (MetE) and construction method thereof |
| 09/21/2011 | CN102191153A Burdock-water caltrop pulp health wine and production method thereof |
| 09/21/2011 | CN102191150A Medlar fermentation health fruit wine |
| 09/21/2011 | CN102191147A Cornus officinalis fruit wine and preparation method thereof |
| 09/21/2011 | CN102190720A Method for preparing human glucagon-like peptide-2 (1-35 peptide) analogue |
| 09/21/2011 | CN102190707A Dendritic cell (DC)-based hepatitis B virus T epitope peptide |
| 09/21/2011 | CN102188718A Application of micromolecule RNA has-miR-29c in preparing medicine treating liver cancer |
| 09/21/2011 | CN102188713A Liver targeting pharmaceutical composition and its preparation method |
| 09/21/2011 | CN102188706A Fluvastatin tablet containing antiflatulent agent |
| 09/21/2011 | CN102188685A Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof |
| 09/21/2011 | CN102188682A Chinese medicinal composition for treating biliary calculus and preparation method thereof |
| 09/21/2011 | CN102188680A Traditional Chinese medicine for treating gastroenteritis |
| 09/21/2011 | CN102188675A Medicine for treating peripheral vertigo, and preparation thereof |
| 09/21/2011 | CN102188671A Chinese medicinal preparation for treating chronic cholecystitis |
| 09/21/2011 | CN102188666A Biliary calculi lithagogue liquor |
| 09/21/2011 | CN102188665A Application of medicinal composition in preparation of medicaments for treating alimentary system inflammation diseases |
| 09/21/2011 | CN102188663A Chinese medicine for treating chronic atrophic gastritis |
| 09/21/2011 | CN102188659A Chinese medicine for treating cirrhosis |
| 09/21/2011 | CN102188655A Molecular Chinese patent medicine for inhibiting defects of Lifei tablets and syndromes of pulmonary tuberculosis |
| 09/21/2011 | CN102188647A Chinese medicinal composition for treating ulcer and inflammation of digestive systems and preparation method thereof |
| 09/21/2011 | CN102188646A Traditional Chinese medicines for increasing native chicken production |
| 09/21/2011 | CN102188645A Medicament for treating ascites and preparation method thereof |
| 09/21/2011 | CN102188642A Weight-losing and body-building health-care wine and preparation method thereof |
| 09/21/2011 | CN102188641A Medicament for treating stomach diseases |
| 09/21/2011 | CN102188640A Chinese medicinal damp-heat external application bag for clearing heat and detoxicating |
| 09/21/2011 | CN102188628A Nutrition tablets for tonifying kidney, strengthening yang and enhancing immunity for men, and preparation method thereof |
| 09/21/2011 | CN102188620A Method for extracting total Dendrobium alkaloids from Dendrobium nobile Lindl waste residue |
| 09/21/2011 | CN102188618A Formula of body fluid promoting effervescent tablets and preparation method thereof |
| 09/21/2011 | CN102188617A Capsules or tablets for treating recurrent aphthous ulcer |
| 09/21/2011 | CN102188614A Capsule for gastric ulcer |
| 09/21/2011 | CN102188605A Health-care wine |
| 09/21/2011 | CN102188598A Chinese medicine formula for improving response of lamivudine in resisting hepatitis B virus |
| 09/21/2011 | CN102188590A Zengshengping dispersing tablet composition and preparation method thereof |
| 09/21/2011 | CN102188589A Zengshengping oral liquid composition and preparation method thereof |